% | Before Therapy | 1-3 | 4-6 | 7-9 | 10-12 |
---|---|---|---|---|---|
CD3+ | 66 ± 10 % | 74 ± 11 %* | 73 ± 12 %* | 73 ± 8 %* | 73 ± 8 %* |
CD4+ | 47 ± 11 % | 55 ± 10 %* | 51 ± 9 %* | 51 ± 10 %* | 52 ± 9 %* |
CD8+ | 26 ± 7 % | 25 ± 6 % | 28 ± 9 % | 27 ± 7 % | 26 ± 9 % |
CD4+CD25+ | 23 ± 8 % | 24 ± 13 % | 22 ± 8 % | 20 ± 7 % | 20 ± 10 % |
CD3+HLA DR+ | 6 ± 5 % | 6 ± 7 % | 6 ± 5 % | 5 ± 3 % | 5 ± 4 % |
cells/microlitre | |||||
CD3+ | 867 ± 537 | 951 ± 419 | 923 ± 404 | 996 ± 584 | 951 ± 624 |
CD4+ | 630 ± 417 | 720 ± 299 | 642 ± 270 | 718 ± 474 | 689 ± 475 |
CD8+ | 318 ± 176 | 304 ± 126 | 348 ± 161 | 350 ± 154 | 324 ± 215 |
CD4+CD25+ | 314 ±196 | 298 ± 209 | 265 ± 121 | 248 ± 108 | 266 ± 232 |
CD3+HLA DR+ | 69 ± 63 | 49 ± 25 | 75 ± 82 | 59 ± 30 | 61 ± 68 |